greeksoup/ stock research

Arlo Technologies, Inc.: Q1 FY2026 earnings call

What management said about Q1 FY2026, from the documents filed with the SEC on 7 May 2026: press release. Guidance figures: 3 new. The quarter’s numbers.

Key takeaways

  • Revenue grew to $150.4 million: Total revenue was $150.4 million, compared with $141.3 million in the fourth quarter and $119.1 million a year earlier. Source
  • Adjusted EBITDA reached $30.4 million: Adjusted EBITDA was $30.4 million, up 85.3% year over year, with a 20.2% margin against 16.5% in the fourth quarter. Source
  • Revenue guided to $145-$155M: Second quarter revenue is guided to $145 - $155 million; the first quarter guidance had been $135 - $145 million. Source
  • Paid accounts passed 6 million: Cumulative paid accounts reached 6.0 million, up 22.6% year over year. Management called passing 6 million a milestone toward its 10 million target. Source
  • Gross margin rose to 48.3%: GAAP gross margin was 48.3%, up 400 basis points, and non-GAAP gross margin was 50.1%, up 460 basis points, year over year. Source
  • Free cash flow was $25.4 million: Free cash flow was $25.4 million, a 16.9% margin, against $17.9 million in the fourth quarter. Source
  • Aloe Care Health acquired: The Aloe Care Health acquisition extends AI-powered aging-in-place care services with health providers, patients and families. Goodwill rose to $38.5 million and intangible assets to $19.5 million. Source

“Our strong momentum continued into 2026 as Arlo delivered outstanding financial results in the first quarter, generating exceptional revenue growth and profitability.”

Matthew McRae, Chief Executive Officer

Guidance

AreaPeriodFigureAgainst last quarter
Revenue Sourcesecond quarter 2026 (three months ended June 28, 2026)$145 - $155 millionNew
EPS, GAAP diluted Sourcesecond quarter 2026$0.00 - $0.06New
EPS, non-GAAP diluted Sourcesecond quarter 2026$0.17 - $0.23New

What changed from last quarter

  • New guidance: Second quarter 2026 guidance issued for revenue and EPS. The February release had given first quarter 2026 guidance of $135 - $145 million. Source
  • New: Acquisition of Aloe Care Health to expand AI-powered aging-in-place care services with health providers, patients and families. Source
  • New: Strategic investment in Origin Wireless sold, with a $6.4 million gain and a 51% return. Source
  • New: A $50 million share repurchase program was newly authorized, and $8.0 million was repurchased under it in the quarter. Source
  • New: Non-GAAP adjustments now include acquisition-related expense and gain on sale of long-term investment; the prior release listed gain on early lease termination and other non-recurring costs. Source

Results and growth drivers

  • Revenue grew to $150.4 million: Total revenue was $150.4 million, compared with $141.3 million in the fourth quarter and $119.1 million a year earlier. Source
  • Operating income of $7.6 million: Income from operations was $7.6 million, or 5.0% of revenue, compared with a $1.5 million loss a year earlier. Source
  • Net income and diluted EPS: GAAP net income was $14.9 million, with basic EPS of $0.14 and diluted EPS of $0.13. Diluted EPS was $0.05 in the fourth quarter. Source
  • Adjusted EBITDA reached $30.4 million: Adjusted EBITDA was $30.4 million, up 85.3% year over year, with a 20.2% margin against 16.5% in the fourth quarter. Source
  • Non-GAAP EPS rose to $0.28: Non-GAAP diluted EPS was $0.28, compared with $0.22 in the fourth quarter and $0.15 a year earlier. Source

Second quarter guidance

  • Revenue guided to $145-$155M: Second quarter revenue is guided to $145 - $155 million; the first quarter guidance had been $135 - $145 million. Source
  • Non-GAAP EPS guided at $0.17-$0.23: Non-GAAP diluted EPS is guided to $0.17 - $0.23, the same range as the first quarter guidance in the February release. Source
  • GAAP EPS guided at $0.00-$0.06: GAAP diluted EPS is guided to $0.00 - $0.06, with stock-based compensation and other items adding $0.17 per share. Source

“Accelerating profitability resulted in adjusted EBITDA of $30 million and non-GAAP earnings per share of $0.28 which both grew by over 85% year over year,”

Matthew McRae, Chief Executive Officer

Segments and regions

  • Subscriptions and services grew 30.9%: Subscriptions and services revenue was $90.1 million, up 30.9%, and 59.9% of total revenue. Products revenue was $60.3 million against $50.2 million a year earlier. Source
  • EMEA revenue rose from fourth quarter: EMEA revenue was $60.7 million, or 40.3% of total, up from $31.6 million in the fourth quarter. Americas was $84.0 million, or 55.9%, down from $103.9 million. Source
  • APAC revenue held near $5.7 million: APAC revenue was $5.7 million, or 3.8% of total, compared with $5.8 million in the fourth quarter and $6.1 million a year earlier. Source

Products and customers

  • Paid accounts passed 6 million: Cumulative paid accounts reached 6.0 million, up 22.6% year over year. Management called passing 6 million a milestone toward its 10 million target. Source
  • ARR reached $356.9 million: Annual recurring revenue was $356.9 million, up 29.2% year over year, from $330.5 million at the end of the fourth quarter. Source
  • Registered accounts rose to 13.1 million: Cumulative registered accounts were 13.1 million, up from 12.1 million at year-end. The company notes these do not directly correspond to the number of users. Source

“We believe these types of inorganic opportunities combined with the scale of our strategic partnerships will provide additional durable growth vectors on our path to surpass our long-range targets early.”

Matthew McRae, Chief Executive Officer

Costs, margins and pricing

  • Gross margin rose to 48.3%: GAAP gross margin was 48.3%, up 400 basis points, and non-GAAP gross margin was 50.1%, up 460 basis points, year over year. Source
  • Subscriptions margin improved: Subscriptions and services GAAP gross margin was 83.7% and non-GAAP was 85.4%, up 150 and 230 basis points year over year. Source
  • Products margin remained negative: Products GAAP gross margin was negative 4.6%, against negative 16.3% in the fourth quarter and negative 7.7% a year earlier. Source
  • Tariffs raise product costs: Products are manufactured outside the U.S. Management said tariffs raise product costs, which could affect sales and product margin; guidance includes its current tariff estimate. Source
  • Operating expenses rose on R&D: Research and development was $22.8 million, against $16.2 million a year earlier. Sales and marketing was $22.7 million and general and administrative was $18.2 million. Source
  • Headcount edged down to 369: Headcount was 369 at quarter end, compared with 376 at December 31, 2025, and 369 a year earlier. Source

Demand, channel and receivables

  • Receivables rose with days sales outstanding: Accounts receivable were $52.2 million, with 31 days sales outstanding, against 26 days at year-end. Source
  • Channel inventory weeks rose: U.S. retail channel inventory was 13.2 weeks, against 10.1 at year-end. U.S. distribution was 9.5 weeks, against 3.0, and APAC distribution was 8.6 weeks, against 5.2. Source
  • Inventories rose slightly: Inventories were $44.0 million against $41.2 million at year-end, with inventory turns of 5.7 against 5.9. Source

Cash, capital and shareholder returns

  • Free cash flow was $25.4 million: Free cash flow was $25.4 million, a 16.9% margin, against $17.9 million in the fourth quarter. Source
  • Cash and investments rose to $167.5M: Cash, cash equivalents and short-term investments were $167.5 million, up $14.4 million year over year. Source
  • Repurchased $8.0 million of stock: The company repurchased $8.0 million of common stock in the quarter. The cash flow statement shows $7.3 million of repurchases paid. Source
  • Capital expenditures were $2.4 million: Purchases of property and equipment, including capitalized software, were $2.4 million, compared with $2.8 million a year earlier. Source

Strategy and investment

  • Aloe Care Health acquired: The Aloe Care Health acquisition extends AI-powered aging-in-place care services with health providers, patients and families. Goodwill rose to $38.5 million and intangible assets to $19.5 million. Source
  • Inorganic deals and partnerships: Management expects inorganic opportunities and strategic partnerships to add durable growth, on the path to surpassing long-range targets early. Source
  • Capital allocation funded expansion: Management said it used its capital allocation program to expand into new market opportunities, citing the April acquisition of Aloe Care. Source

Coming up, as management said on 7 May 2026

  • Second quarter ends June 28: The second quarter ends June 28, 2026, the period covered by the guidance given in this release. Source

Figures management reported

FigureReported
Cumulative paid accounts Source6,005 thousand (6.0 million)
Cumulative registered accounts Source13,052 thousand (13.1 million)
Annual recurring revenue (ARR) Source$356.9 million

Risks management discussed

  • External: Products are manufactured outside the U.S., and management described the tariff environment as uncertain, with tariffs raising product costs. Source
  • Financial: Guidance excludes items not yet known, such as litigation reserves, impairment charges and discrete tax items, which could significantly affect guidance. Source
  • Regulatory: Guidance may be affected by additional impacts from implementing U.S. tax reform, which management said could have significant effects on results. Source

Earlier plans management reported on

  • Not stated: Management said acquisitions and strategic partnerships are on its path to surpass long-range targets early. Source
  • Not stated: The long-range plan targets 10 million paid accounts. The company reported passing 6 million. Source

Other quarters

Summarised with AI from the documents the company filed with the SEC. Every point is checked against the filing before it is shown: management’s own words word for word, figures against the line or table row they come from. A point that fails the check is left out. Source opens the filing at that line.